English | Español
Patient Daily | Feb 22, 2026

Analysis finds most English regions fall short on safe GP staffing levels
Patient Daily | Feb 22, 2026

Researchers outline risks linked to widely used diabetes and weight-loss drugs
Patient Daily | Feb 22, 2026

Positrigo introduces program to expand access to brain PET imaging in U.S. neurology offices
Patient Daily | Feb 22, 2026

Boomerang Ventures invests in IMPOWER HEALTH; appoints Trent McCracken as CEO
Patient Daily | Feb 22, 2026

Ocular Therapeutix’s hydrogel shows stronger results than Eylea in late-stage wet AMD trial
Patient Daily | Feb 22, 2026

Vaxart advances oral norovirus vaccine as rivals face clinical challenges
Patient Daily | Feb 22, 2026

Compass Pathways reports positive phase 3 results for psilocybin-based depression therapy
Patient Daily | Feb 22, 2026

Disc Medicine faces regulatory uncertainty after FDA rejects rare disease drug

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'